Asia
Porton Pharma Solutions' Unit Gets Manufacturing License
Porton Pharma Solutions' (SHE:300363) unit, Suzhou Porton Biopharmaceutical, obtained a pharmaceutical manufacturing license from the Jiangsu Provincial Medical Products Administration, according to a Shenzhen bourse filing on Monday.The Chinese biotech company's shares jumped 14% at the close of Tuesday's trade.Suzhou Porton's manufacturing scope includes therapeutic biological products.The license is valid until July 26, 2031.
SHE:300363
